Assessing the Risks of Counterfeiting and Illicit Diversion for Health Care Products is a paper series published by the Center for Anti-Counterfeiting and Product Protection (A-CAPP) at Michigan State University. The paper addresses the threats of counterfeit products in the healthcare industry and how they affect businesses within the industry. Additionally, the report examines the global supply chain and counterfeit threats of pharmaceuticals. This resource opens in PDF.